

"The global market leader in objective ADHD testing and treatment monitoring for children and adults"
Qbtech develops FDA-cleared ADHD tests that combine objective data with subjective information to support healthcare providers in diagnosis and treatment evaluation. The company's technology measures core ADHD symptoms through computerized testing and motion tracking, providing evidence-based reports that help clinicians make confident decisions for patients aged 6 to 60. Over 12,000 healthcare providers across 14 countries use Qbtech's solutions, which have supported more than one million patients. The technology addresses the complexity of ADHD diagnosis by offering objective measurement alongside traditional assessment methods, helping to reduce diagnostic delays and improve outcomes for children and adults living with ADHD.


117
Team Members
2002
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where everyone with ADHD has access to reliable, effective care that improves their quality of life and helps them reach their full potential.
At Qbtech, our mission is to improve the lives of those with ADHD by providing technology-driven solutions that combine objective and subjective data to enable outcome-focused care.